doxorubicin (Immunomedics)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug Namedoxorubicin (Immunomedics)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics

Mechanisms of ActionDNA intercalatorsVirus DNA polymerase inhibitorsTopoisomerase II inhibitors

TargetsVirus DNA polymeraseTopoisomerase IIDNA

Therapy Area/IndicationsColonic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsColonic NeoplasmsNeoplasms

ATC CodeN/A